Clinical Trial Update: Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study evaluated the safety and efficacy of topical resiquimod in patients with multiple actinic keratosis lesions. The trial has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Resiquimod (resiquimod)

Snippet

Sponsor: Spirig Pharma Ltd. | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED